Described are deuterium-substituted oxazepin compounds of structural Formula I, which are inhibitors/blockers of the late sodium current. Also described are pharmaceutical compositions comprising the deuterium-substituted oxazepin compounds, and methods of use thereof.
[EN] PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS<br/>[FR] PROCÉDÉS DE PRÉPARATION DE MODULATEURS DES CANAUX IONIQUES HÉTÉROCYCLIQUES CONDENSÉS
申请人:GILEAD SCIENCES INC
公开号:WO2015123519A2
公开(公告)日:2015-08-20
The present disclosure provides processes for the preparation of a compound of formula: which is a selective late sodium current inhibitor. The disclosure also provides compounds that are synthetic intermediates.
[EN] DEUTERIUM-SUBSTITUTED OXAZEPIN COMPOUNDS<br/>[FR] COMPOSÉS D'OXAZÉPIN À SUBSTITUTION PAR DU DEUTÉRIUM
申请人:AUSPEX PHARMACEUTICALS INC
公开号:WO2018048977A1
公开(公告)日:2018-03-15
Described are deuterium-substituted oxazepin compounds of structural Formula I, which are inhibitors/blockers of the late sodium current. Also described are pharmaceutical compositions comprising the deuterium-substituted oxazepin compounds, and methods of use thereof. (I)
PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS
申请人:Gilead Sciences, Inc.
公开号:US20150225384A1
公开(公告)日:2015-08-13
The present disclosure provides processes for the preparation of a compound of formula:
which is a selective late sodium current inhibitor. The disclosure also provides compounds that are synthetic intermediates.